HomeAREC • LON
add
Arecor Therapeutics PLC
Previous close
GBX 72.50
Day range
GBX 66.75 - GBX 70.00
Year range
GBX 35.40 - GBX 100.00
Market cap
25.20M GBP
Avg Volume
31.10K
P/E ratio
-
Dividend yield
-
Primary exchange
LON
Market news
MarketScreener
40 minutes ago
GSR IV Acquisition Corp.(NasdaqGM: GSRF) added to NASDAQ Composite Index
1.08%
1.65%
1.37%
Financials
Income Statement
Revenue
Net income
| (GBP) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 1.00M | 0.40% |
Operating expense | 1.65M | -35.36% |
Net income | -1.25M | 45.95% |
Net profit margin | -125.21 | 46.16% |
Earnings per share | — | — |
EBITDA | -1.43M | 38.00% |
Effective tax rate | 1.34% | — |
Balance Sheet
Total assets
Total liabilities
| (GBP) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.89M | -25.89% |
Total assets | 5.25M | -49.35% |
Total liabilities | 2.39M | -54.73% |
Total equity | 2.86M | — |
Shares outstanding | 37.76M | — |
Price to book | 9.06 | — |
Return on assets | -70.71% | — |
Return on capital | -122.57% | — |
Cash Flow
Net change in cash
| (GBP) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -1.25M | 45.95% |
Cash from operations | -585.00K | 72.20% |
Cash from investing | 19.00K | -97.74% |
Cash from financing | -34.00K | -4.62% |
Net change in cash | -686.00K | 46.49% |
Free cash flow | -853.12K | 36.75% |
About
Founded
2007
Website
Employees
44
